Abstract:Rationale: Machine learning may be useful to characterize cardiovascular risk, predict outcomes, and identify biomarkers in population studies. Objective: To test the ability of random survival forests, a machine learning technique, to predict 6 cardiovascular outcomes in comparison to standard cardiovascular risk scores. Methods and results: We included participants from the MESA (Multi-Ethnic Study of Atherosclerosis). Baseline measurements were used to predict cardiovascular outcomes over 12 years of follow-up. MESA was designed to study progression of subclinical disease to cardiovascular events where participants were initially free of cardiovascular disease. All 6814 participants from MESA, aged 45 to 84 years, from 4 ethnicities, and 6 centers across the United States were included. Seven-hundred thirty-five variables from imaging and noninvasive tests, questionnaires, and biomarker panels were obtained. We used the random survival forests technique to identify the top-20 predictors of each outcome. Imaging, electrocardiography, and serum biomarkers featured heavily on the top-20 lists as opposed to traditional cardiovascular risk factors. Age was the most important predictor for all-cause mortality. Fasting glucose levels and carotid ultrasonography measures were important predictors of stroke. Coronary Artery Calcium score was the most important predictor of coronary heart disease and all atherosclerotic cardiovascular disease combined outcomes. Left ventricular structure and function and cardiac troponin-T were among the top predictors for incident heart failure. Creatinine, age, and ankle-brachial index were among the top predictors of atrial fibrillation. TNF-α (tissue necrosis factor-α) and IL (interleukin)-2 soluble receptors and NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) levels were important across all outcomes. The random survival forests technique performed better than established risk scores with increased prediction accuracy (decreased Brier score by 10%-25%). Conclusions: Machine learning in conjunction with deep phenotyping improves prediction accuracy in cardiovascular event prediction in an initially asymptomatic population. These methods may lead to greater insights on subclinical disease markers without apriori assumptions of causality. Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00005487.

Advancing Cardiovascular Mortality Trend Analysis: A Machine Learning Approach to Predict Future Health Policy Needs

Nationwide Mortality Trends from 2001 to 2020 in Greece: Health Policy Implications under the Scope of Aging Societies

Advanced Techniques in Mortality Trend Estimation: Integrating Generalized Additive Models and Machine Learning to Evaluate the COVID-19 Impact

Comparison of Machine Learning Techniques for Mortality Prediction in a Prospective Cohort of Older Adults

Improving Cardiovascular Risk Prediction Through Machine Learning Modelling of Irregularly Repeated Electronic Health Records

Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis

Forecasting Leading Death Causes in Australia using Extended CreditRisk$+$

Risk Prediction Model for In-Hospital Mortality in Women with ST-elevation Myocardial Infarction: A Machine Learning Approach

Predicting mortality in the very old: a machine learning analysis on claims data

Demographic forecasting of population aging in Greece and Cyprus: one big challenge for the Mediterranean health and social system long-term sustainability

Machine learning-based prognostication of mortality in stroke patients

Predicting short and long-term mortality after acute ischemic stroke using EHR

Efficient Data-Driven Machine Learning Models for Cardiovascular Diseases Risk Prediction

Probabilistic mortality forecasting with varying age-specific survival improvements

Machine learning predicts long-term mortality after acute myocardial infarction using systolic time intervals and routinely collected clinical data

Application of Machine Learning in Identifying Premature Aging

Towards artificial intelligence-based learning health system for population-level mortality prediction using electrocardiograms

Predicting Future Birth Rates with the Use of an Adaptive Machine Learning Algorithm: A Forecasting Experiment for Scotland

Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis

Artificial intelligence for predicting mortality in hospitalized COVID-19 patients

Short-term Mortality Prediction for Elderly Patients Using Medicare Claims Data